CEFA-TABS 50MG DIN 00844284
Status: Cancelled Post Market
Holder: WYETH ANIMAL HEALTH, DIVISION OF WYETH CANADA
Molecule: CEFADROXIL (CEFADROXIL MONOHYDRATE)
Health Canada record
| Active ingredient(s) | CEFADROXIL (CEFADROXIL MONOHYDRATE) 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1990 |
| Current status date | 21-Jul-2011 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFADROXIL (CEFADROXIL MONOHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02544792 | JAMP CEFADROXIL | JAMP PHARMA CORPORATION | Capsule | CEFADROXIL (CEFADROXIL MONOHYDRATE) 500 MG | Marketed |
| 02235134 | TEVA-CEFADROXIL | TEVA CANADA LIMITED | Capsule | CEFADROXIL (CEFADROXIL MONOHYDRATE) 500 MG | Marketed |
| 02195895 | CEFA-DROPS | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Powder For Suspension | CEFADROXIL (CEFADROXIL MONOHYDRATE) 50 MG | Cancelled Post Market |
| 00844241 | CEFA-TABS 100MG | WYETH ANIMAL HEALTH, DIVISION OF WYETH CANADA | Tablet | CEFADROXIL (CEFADROXIL MONOHYDRATE) 100 MG | Cancelled Post Market |
| 00844233 | CEFA-TABS 200MG | WYETH ANIMAL HEALTH, DIVISION OF WYETH CANADA | Tablet | CEFADROXIL (CEFADROXIL MONOHYDRATE) 200 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 3443 | 2003-07-08 | New Drug Submission (NDS) | |
| 5840 | 1998-06-18 | New Drug Submission (NDS) |